Skip to main content
. 2015 Jun 30;5:11781. doi: 10.1038/srep11781

Figure 5. GCN2−/− mixed background sarcomas do not express lower levels of ATF4, in spite of reduced eIF2α phosphorylation.

Figure 5

(a) Western blot analysis on two independent samples of tumor homogenates for levels of ATF4 in mixed background tumors. β-tubulin was used as a loading control. The ratio of ATF4 to β-tubulin is displayed below each blot. (b) Graphical representation of the ATF4 to β-tubulin ratios calculated from the blots in (a). Data are represented as the average value for each genotype ± standard deviation. Results are not statistically significant. (c) qPCR analysis of ASNS levels in GCN2+/+ and GCN2−/− sarcomas. ASNS levels were normalized to the geometric mean of the reference genes β-tubulin, β-actin, and 18S rRNA. Data are represented as the average value for each genotype ± standard deviation. Results are not statistically significant. (d) qPCR analysis of ATF3 levels in GCN2+/+ and GCN2−/− sarcomas. ATF3 levels were normalized to the geometric mean of the reference genes β-tubulin, β-actin, and 18S rRNA. Data are represented as the average value for each genotype ± standard deviation. Results are not statistically significant. (e) qPCR analysis of ULK1 levels in GCN2+/+ and GCN2−/− sarcomas. ULK1 levels were normalized to the geometric mean of the reference genes β-tubulin, β-actin, and 18S rRNA. Data are represented as the average value for each genotype ± standard deviation. Results are not statistically significant.